Release Date: 19/10/18 17:55 Summary: Notice of Annual General Meeting/Proxy Form Price Sensitive: No Download Document 1.01MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%